...
首页> 外文期刊>Hong Kong medical journal = >Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go
【24h】

Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go

机译:T1肾癌的部分肾切除术可以达到与根治性肾切除术相同的肿瘤学结局,并能更好地保护肾脏:

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Patients who undergo partial nephrectomy have been shown to be at decreased risk of renal impairment compared with radical nephrectomy. We examined the oncological outcome of patients in our centre who underwent partial or radical nephrectomy for T1 renal cancer (7 cm or smaller), and compared the likelihood of developing chronic kidney disease. Methods: This historical cohort study with internal comparison was conducted in a tertiary hospital in Hong Kong. A cohort of 86 patients with solitary T1 renal cancer and a normal contralateral kidney who underwent radical (38 patients) or partial (48 patients) nephrectomy between January 2005 and December 2010 was included. The overall and cancer-free survival, change in glomerular filtration rate, and new onset of chronic kidney disease were compared between the radical and partial nephrectomy groups. Results: A total of 32 (84%) radical nephrectomy patients and 43 (90%) partial nephrectomy patients were alive by 31 December 2012. The mean follow-up was 43.5 (standard deviation, 22.4) months. There was no significant difference in overall survival (P=0.29) or cancer-free survival (P=0.29) between the two groups. Both groups enjoyed good oncological outcome with no recurrence in the partial nephrectomy group. Overall, 18 (21%) patients had pre-existing chronic kidney disease. The partial nephrectomy group had a significantly smaller median reduction in glomerular filtration rate (12.6% vs 35.4%; PConclusions: Compared with radical nephrectomy, partial nephrectomy can prevent chronic kidney disease and still achieve an excellent oncological outcome for T1 renal tumours, in particular T1a tumours and tumours with a low R.E.N.A.L. score.
机译:简介:与根治性肾切除术相比,部分肾切除术的肾脏损害风险已降低。我们检查了我们中心接受部分或根治性肾切除术治疗T1肾癌(7厘米或更小)的患者的肿瘤学结局,并比较了发生慢性肾脏疾病的可能性。方法:这项具有内部比较的历史队列研究是在香港一家三级医院进行的。纳入了2005年1月至2010年12月间行根治性手术(38例)或部分肾切除术(48例)的86例孤立性T1肾癌和正常对侧肾脏患者。比较了根治性和部分肾切除术组的总体生存率和无癌生存率,肾小球滤过率的变化以及慢性肾脏疾病的新发作。结果:截止2012年12月31日,共有32例(84%)根治性肾切除术患者和43例(90%)局部肾切除术患者还活着。平均随访时间为43.5(标准差,22.4)个月。两组的总生存期(P = 0.29)或无癌生存期(P = 0.29)无显着差异。两组均在部分肾切除术组中具有良好的肿瘤学结局且无复发。总体而言,有18位(21%)患者患有慢性肾脏病。部分肾切除术组的肾小球滤过率中位数下降幅度明显较小(12.6%比35.4%; PConclusions):与根治性肾切除术相比,部分肾切除术可以预防慢性肾脏疾病,并且对于T1肾肿瘤(尤其是T1a)仍具有良好的肿瘤学结肿瘤和具有较低RENAL分数的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号